New Bill Will Propose Mandating Price Transparency in Healthcare

June 11, 2018

Sen. Bill Cassidy (R-La.) recently said that he hopes to soon introduce legislation mandating price transparency in health care to enable patients to compare prices before getting procedures, according to The Hill. He also plans to introduce legislation on drug prices, including banning “gag clauses” that prevent pharmacists from informing patients when they could save money on a drug by paying cash instead of using insurance.

cassidybill_030618gn_lead.jpg

Sen. Bill Cassidy (R-La.), copyright of Greg Nash via The Hill. 

The Hill reports that Cassidy and a bipartisan group of senators first sought feedback on the idea in March. Cassidy told Fox News Radio that the legislation would mean that “if somebody gets an X-ray order for their child's belly, they will know the cost of that before they go in to get it done and they can price shop.”

While this sounds like a solid plan, Democrats caution an aspect of Cassidy’s recent ideas, which calls for codifying a Trump administration regulation expanding cheaper, skimpier short-term insurance plans that do not need to meet ObamaCare requirements. Opposition may also come from larger healthcare industry groups.

“Cassidy wants to finalize the Trump Administration’s junk plan proposal to stick millions of Americans with skimpy plans that can discriminate against people with pre-existing conditions, refuse to cover essential services like hospitalization or prescription drugs and stick unsuspecting patients with enormous medical bills,” said Brad Woodhouse, campaign director for the pro-ObamaCare group Protect Our Care.

Read more on this story on The Hill.


Comment on This Article   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Lawmakers Reject Amendment to Require Drug Pricing in TV Ads
Are Rebates the New Villain of High Drug Prices?
Drug Makers Game the System

Featured Articles

Surprise Billing: Arbitration Will Raise Your Premiums
SB 432 – Lots of Treats for Pharmacists – and Bad News for Consumers
Why do Pharmaceutical Companies hate PBMs so much?
Creators of Mysterious Ad Blitz Influencing Anti-Surprise Billing Law Comes to Light
Benchmarking, Not Arbitration, is the Answer to America’s Surprise Billing Problem
Podcast: Senator Joyce Krawiec Talks to Us About Why CON Laws are Bad for NC